Prostaglandins and cyclic nucleotides modulators of arterial cholesterol metabolism
- 1 February 1985
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (3) , 295-300
- https://doi.org/10.1016/0006-2952(85)90034-6
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- PROSTACYCLIN ANALOGUES AS ANTIATHEROSCLEROTIC DRUGSThe Lancet, 1983
- Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aortaBiochemical and Biophysical Research Communications, 1982
- Decreased prostaglandin production in cultured smooth muscle cells from atherosclerotic rabbit aortaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aortaNature, 1980
- Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation?Cellular and Molecular Life Sciences, 1980
- Injury to human endothelial cells in culture induced by low density lipoproteinsScandinavian Journal of Clinical and Laboratory Investigation, 1979
- Inhibition of cholesterol esterification in rabbit aorta by prostaglandin E2Atherosclerosis, 1977
- Activation of adrenal Sterol Ester Hydrolase by dibutyryl cAMP and protein kinaseBiochemical and Biophysical Research Communications, 1974
- Regulation of cellular sterol flux and synthesis by human serum lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1974
- Stimulation by insulin of rat liver β-hydroxy-β-methylglutaryl coenzyme A reductase and cholesterol-synthesizing activitiesBiochemical and Biophysical Research Communications, 1973